Armstrong Pharmaceuticals has announced that pending FDA-approval, Primatene Mist HFA (epinephrine inhalation aerosol) will replace Primatene Mist containing chloroflurocarbons (CFCs) propellants.

Amphastar announced that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Primatene MIST (epinephrine inhalation aerosol bronchodilator suspension) for the ...

In the United States, Primatene Mist (epinephrine inhalation aerosol bronchodilator suspension, Amphastar Pharmaceuticals Inc.) is the only asthma inhaler that is FDA-approved and available ...

The epinephrine inhaler was developed as a replacement for Primatene Mist (epinephrine metered inhaler 200 mcg/actuation), an OTC product that was phased out in December 2011 because of the use of ...

— A pair of Food and Drug Administration advisory committees on Tuesday voted against the over-the-counter sale of Armstrong Pharmaceuticals' Primatene HFA, an epinephrine inhalation aerosol ...

The original Primatene Mist was discontinued in 2011 as the inhaler’s ozone-depleting propellant had been banned.

The U.S. Food and Drug Administration has approved a new version of Primatene Mist, an over-the-counter inhaler for mild asthma.

The newly approved, patented formulation of Primatene ® MIST is made with the same active ingredient, epinephrine, which was used in the original Primatene ® Mist before it was removed from the ...

US Food and Drug Administration (FDA) advisory panels have voted (18 no, 6 yes, 1 no vote) not to recommend over-the-counter (OTC) marketing of epinephrine inhalation aerosol 125 microgram (mcg ...

A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved its over-the-counter aerosol inhaler for ages 12 and up.

(RTTNews) - After 7 years of absence, asthma inhaler Primatene Mist, developed by Amphastar Pharmaceuticals, is reentering the market with renewed features. The over-the-counter epinephrine ...